This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Santos, R. A. Articles by Greene, L. J. Search for Related Content PubMed PubMed Citation Articles by Santos, R. A. Articles by Greene, L. J.

Hypertension, Vol 7, 244-252, Copyright © 1985 by American Heart Association

ARTICLES

An improved fluorometric assay of rat serum and plasma converting enzyme

RA Santos, EM Krieger and LJ Greene

The most sensitive nonradiometric routine assay for angiotensin- converting enzyme (ACE) activity uses fluorometry to detect His-Leu released from Hip-His-Leu. Our results indicate that, in contrast to human serum, rat serum and plasma contain large and variable amounts of dipeptidase activity that lead to a subestimation of the ACE activity measured in 0.1 M potassium phosphate buffer, pH 8.3, containing 0.3 M NaCl, the most commonly used assay for human serum and tissue ACE. We describe and validate an assay for 1 to 10 microL rat and human serum or plasma using 5 mM Hip-His-Leu in 500 microL of 0.4 M sodium borate buffer, pH 8.3, containing 0.9 M NaC1 at 37 degrees C that reduced the subestimation error to less than or equal to 3% (rat serum) and less than or equal to 0.1% (human serum) and increased the ACE activity twofold to threefold. The Km and Vmax are reported for rat serum ACE (Hip-His-Leu) and dipeptidase (His-Leu) in borate buffer and phosphate buffer. Rat serum ACE hydrolysis of Hip-His-Leu measured by fluorometry correlated (r = 0.99, p less than 0.05) with the hydrolysis of angiotensin I measured by high-performance liquid chromatography. A direct method based on amino acid analysis is described for evaluating the dipeptidase error of complex mixtures such as tissue extracts and other physiological fluids. We have found that the assay can be used to measure ACE activity in 25 samples (in duplicate) in 2 hours with small intraassay (2.2%) and interassay (3.9%) coefficients of variation.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				V. M. Pereira, F. M. Reis, R. A. S. Santos, G. D. Cassali, S. H. S. Santos, K. Honorato-Sampaio, and A. M. dos Reis Gonadotropin Stimulation Increases the Expression of Angiotensin-(1--7) and Mas Receptor in the Rat Ovary Reproductive Sciences, December 1, 2009; 16(12): 1165 - 1174. [Abstract] [PDF]

				X. Liu, C. O. C. Bellamy, M. A. Bailey, L. J. Mullins, D. R. Dunbar, C. J. Kenyon, G. Brooker, S. Kantachuvesiri, K. Maratou, A. Ashek, et al. Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage J. Biol. Chem., June 5, 2009; 284(23): 15564 - 15572. [Abstract] [Full Text] [PDF]

				R. A. Lew, F. J. Warner, I. Hanchapola, M. A. Yarski, J. Manohar, L. M. Burrell, and A. I. Smith Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor Exp Physiol, May 1, 2008; 93(5): 685 - 693. [Abstract] [Full Text] [PDF]

				M. B.L. Carvalho, F. V. Duarte, R. Faria-Silva, B. Fauler, L. T. da Mata Machado, R. D. de Paula, M. J. Campagnole-Santos, and R. A.S. Santos Evidence for Mas-Mediated Bradykinin Potentiation by the Angiotensin-(1-7) Nonpeptide Mimic AVE 0991 in Normotensive Rats Hypertension, October 1, 2007; 50(4): 762 - 767. [Abstract] [Full Text] [PDF]

				P. van der Harst, T. D.J. Smilde, H. Buikema, A. A. Voors, G. Navis, D. J. van Veldhuisen, and W. H. van Gilst Vascular Function and Mild Renal Impairment in Stable Coronary Artery Disease Arterioscler Thromb Vasc Biol, February 1, 2006; 26(2): 379 - 384. [Abstract] [Full Text] [PDF]

				M. C. Camargo de Andrade, G. S. Di Marco, V. de Paulo Castro Teixeira, R. A. Mortara, R. A. Sabatini, J. B. Pesquero, M. A. Boim, A. K. Carmona, N. Schor, and D. E. Casarini Expression and localization of N-domain ANG I-converting enzymes in mesangial cells in culture from spontaneously hypertensive rats Am J Physiol Renal Physiol, February 1, 2006; 290(2): F364 - F375. [Abstract] [Full Text] [PDF]

				M. L. Hemming and D. J. Selkoe Amyloid {beta}-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor J. Biol. Chem., November 11, 2005; 280(45): 37644 - 37650. [Abstract] [Full Text] [PDF]

				P. van der Harst, M. Volbeda, A. A. Voors, H. Buikema, S. Wassmann, M. Bohm, G. Nickenig, and W. H. van Gilst Vascular Response to Angiotensin II Predicts Long-Term Prognosis in Patients Undergoing Coronary Artery Bypass Grafting Hypertension, December 1, 2004; 44(6): 930 - 934. [Abstract] [Full Text] [PDF]

				G. D.M. Marques, B. M.R. Quinto, F. L. Plavinik, J. E. Krieger, O. Marson, and D. E. Casarini N-Domain Angiotensin I-Converting Enzyme With 80 kDa as a Possible Genetic Marker of Hypertension Hypertension, October 1, 2003; 42(4): 693 - 701. [Abstract] [Full Text] [PDF]

				R. A.S. Santos, A. S. Haibara, M. J. Campagnole-Santos, A. C. Simoes e Silva, R. D. Paula, S. V.B. Pinheiro, M. de Fatima Leite, V. S. Lemos, D. M.R. Silva, M. T. Guerra, et al. Characterization of a New Selective Antagonist for Angiotensin-(1-7), D-Pro7-Angiotensin-(1-7) Hypertension, March 1, 2003; 41(3): 737 - 743. [Abstract] [Full Text] [PDF]

				S. G. Lage, L. Kopel, C. C. J. Medeiros, R. T. Carvalho, and M. A. Creager Angiotensin II contributes to arterial compliance in congestive heart failure Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1424 - H1429. [Abstract] [Full Text] [PDF]

				M. Barton, R. Carmona, H. Morawietz, L. V. d'Uscio, W. Goettsch, H. Hillen, C. C. Haudenschild, J. E. Krieger, K. Munter, T. Lattmann, et al. Obesity Is Associated With Tissue-Specific Activation of Renal Angiotensin-Converting Enzyme In Vivo : Evidence for a Regulatory Role of Endothelin Hypertension, January 1, 2000; 35(1): 329 - 336. [Abstract] [Full Text] [PDF]

				J. Xavier-Neto, A. C. Pereira, M. d. L. Junqueira, R. Carmona, and J. E. Krieger Rat Angiotensin-Converting Enzyme Promoter Regulation by {beta}-Adrenergics and cAMP in Endothelium Hypertension, July 1, 1999; 34(1): 31 - 38. [Abstract] [Full Text] [PDF]

				R. R. Britto, R. A. S. Santos, C. R. Fagundes-Moura, M. C. Khosla, and M. J. Campagnole-Santos Role of Angiotensin-(1-7) in the Modulation of the Baroreflex in Renovascular Hypertensive Rats Hypertension, September 1, 1997; 30(3): 549 - 556. [Abstract] [Full Text]

				M. J. Rieder, R. J. Roman, and A. S. Greene Reversal of Microvascular Rarefaction and Reduced Renal Mass Hypertension Hypertension, July 1, 1997; 30(1): 120 - 127. [Abstract] [Full Text]

				M. J. Rieder, R. Carmona, J. E. Krieger, K. A. Pritchard Jr, and A. S. Greene Suppression of Angiotensin-Converting Enzyme Expression and Activity by Shear Stress Circ. Res., March 1, 1997; 80(3): 312 - 319. [Abstract] [Full Text]

				L. Stallard and P. G. Reeves Zinc Deficiency in Adult Rats Reduces the Relative Abundance of Testis-Specific Angiotensin-Converting Enzyme mRNA J. Nutr., January 1, 1997; 127(1): 25 - 29. [Abstract] [Full Text]